Details for New Drug Application (NDA): 216877
✉ Email this page to a colleague
The generic ingredient in TRANEXAMIC ACID is tranexamic acid. There are eight drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the tranexamic acid profile page.
Summary for 216877
Tradename: | TRANEXAMIC ACID |
Applicant: | Nexus |
Ingredient: | tranexamic acid |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 216877
Physiological Effect | Decreased Fibrinolysis |
Medical Subject Heading (MeSH) Categories for 216877
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | 1GM/100ML (10MG/ML) | ||||
Approval Date: | Apr 16, 2024 | TE: | AP | RLD: | No |
Complete Access Available with Subscription